Literature DB >> 9694052

Soluble intercellular adhesion molecule 1 in spondylarthropathies.

D Wendling1, E Racadot, B Augé, E Toussirot.   

Abstract

The aim of the study was to evaluate the soluble form of intercellular adhesion molecule 1 (sICAM-1), a ligand of LFA-1, in the serum of patients with spondylarthropathies (SpA) and to look for a correlation with several inflammatory parameters. sICAM-1 levels were measured by ELISA in 25 SpA patients, 20 healthy controls and 20 patients with rheumatoid arthritis (RA). Results showed that sICAM-1 levels were increased (but not significantly) in SpA patients compared with controls; high levels (> 400 ng/ml) where found in 28% of SpA patients but in none of the RA or control groups. In SpA, correlations were found between sICAM-1 and erythrocyte sedimentation rate, C-reactive protein and interleukin 6, but not with tumour necrosis factor alapha or IgA. These correlations were absent in RA. In conclusion, these results suggest that sICAM-1 levels in SpA may reflect the acute phase of inflammation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694052     DOI: 10.1007/bf01451047

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  [Adhesion molecules in inflammatory rheumatisms].

Authors:  D Wendling
Journal:  Presse Med       Date:  1993-12-11       Impact factor: 1.228

2.  Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.

Authors:  Z N Tutuncu; A Bilgie; L G Kennedy; A Calin
Journal:  Ann Rheum Dis       Date:  1994-06       Impact factor: 19.103

3.  A form of circulating ICAM-1 in human serum.

Authors:  R Rothlein; E A Mainolfi; M Czajkowski; S D Marlin
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

Review 4.  The adhesion molecules of inflammation.

Authors:  B N Cronstein; G Weissmann
Journal:  Arthritis Rheum       Date:  1993-02

5.  Adhesion molecules in rheumatoid arthritis: role in the pathogenesis and prospects for therapy.

Authors:  C Pitzalis; G Kingsley; G Panayi
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

6.  Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leucocyte adhesion molecule are increased in patients with rheumatoid vasculitis.

Authors:  A E Voskuyl; S Martin; L Melchers; A H Zwinderman; I Weichselbraun; F C Breedveld
Journal:  Br J Rheumatol       Date:  1995-04

7.  Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis.

Authors:  J J Cush; R Rothlein; H B Lindsley; E A Mainolfi; P E Lipsky
Journal:  Arthritis Rheum       Date:  1993-08

8.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

9.  Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity.

Authors:  J Gratacós; A Collado; X Filella; R Sanmartí; J Cañete; J Llena; R Molina; A Ballesta; J Muñoz-Gómez
Journal:  Br J Rheumatol       Date:  1994-10

10.  Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis.

Authors:  S Aoki; K Imai; A Yachi
Journal:  Scand J Immunol       Date:  1993-11       Impact factor: 3.487

View more
  5 in total

1.  Soluble ICAM-1 serum levels in patients with intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

2.  Up-regulation of soluble P-selectin predicates its prognostic value in patients with ankylosing spondylitis.

Authors:  Xianwei Zhou; Wuyin Li; Qiang Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

3.  Serum markers associated with clinical improvement in patients with ankylosing spondylitis treated with golimumab.

Authors:  Carrie Wagner; Sudha Visvanathan; Jürgen Braun; Désirée van der Heijde; Atul Deodhar; Benjamin Hsu; Michael Mack; Michael Elashoff; Robert D Inman
Journal:  Ann Rheum Dis       Date:  2011-10-28       Impact factor: 19.103

Review 4.  Endothelial dysfunction in chronic inflammatory diseases.

Authors:  Curtis M Steyers; Francis J Miller
Journal:  Int J Mol Sci       Date:  2014-06-25       Impact factor: 5.923

5.  Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.

Authors:  Hanna Przepiera-Będzak; Katarzyna Fischer; Marek Brzosko
Journal:  Int J Mol Sci       Date:  2016-08-03       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.